AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Evogene's CEO to present at H.C. Wainwright Global Investment Conference 2025.
ByAinvest
Thursday, Aug 28, 2025 7:06 am ET1min read
Evogene Ltd. announced that CEO Ofer Haviv will present at the H.C. Wainwright 27th Annual Global Investment Conference in New York on September 8-10, 2025. Haviv will highlight the company's new strategic focus on maximizing the value of ChemPass AI, a generative AI tech-engine for small molecule discovery and optimization in pharmaceuticals and agriculture. The presentation is scheduled for September 10, 2025, at 1:00 PM ET, and Haviv will be available for one-on-one meetings.
Evogene Ltd. (NASDAQ: EVGN) has announced that CEO Ofer Haviv will present at the H.C. Wainwright 27th Annual Global Investment Conference in New York from September 8-10, 2025. Haviv's presentation, scheduled for September 10, 2025, at 1:00 PM ET, will focus on the company's strategic shift towards maximizing the value of ChemPass AI, a proprietary generative AI tech-engine for small molecule discovery and optimization in pharmaceuticals and agriculture [1][2].The presentation will highlight Evogene's new strategic focus on leveraging ChemPass AI to address key challenges in small molecule discovery and optimization. By utilizing its tech-engine, Evogene aims to increase the probability of success while reducing time and development costs. The company's powerful tech-engine drives product innovation through strategic partnerships and collaborations, as well as through its internal proprietary product pipelines [2].
Haviv will be available for one-on-one meetings with interested investors and companies attending the conference. The event provides an opportunity for attendees to gain insights into Evogene's innovative approach to small molecule discovery and optimization, and to discuss potential collaboration opportunities [1][2].
References:
[1] https://www.stocktitan.net/news/EVGN/evogene-to-present-at-h-c-wainwright-27th-annual-global-investment-rv446tvcm7no.html
[2] https://www.prnewswire.com/news-releases/evogene-to-present-at-hc-wainwright-27th-annual-global-investment-conference-in-new-york-302540962.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet